Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients.
Biomark Res
; 9(1): 78, 2021 Oct 29.
Article
in En
| MEDLINE
| ID: mdl-34715925
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Biomark Res
Year:
2021
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom